TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ASND

Ascendis Pharma AS

Healthcare · Biotechnology

230.10$ +2.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Ascendis Pharma AS (ASND) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,302 million EUR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ASND
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
59 132 190 211 319 677 980 1,085 1,090 826 1,179 1,302
53 126 184 205 293 611 740 806 923 703 1,061 1,109
50 120 180 195 278 598 585 446 445 392 560 616
50 120 180 195 278 598 719 682 735 399 560 616
1.3 1.1 0.3 0.2 0.0 0.8 0.4 2.2 12 36 166 158
0.0 0.0 0.0 0.0 0.0 0.0 0.0 75 131 209 296 301
2.7 2.4 2.4 2.6 4.3 45 108 126 129 – – –
3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5
3.5 3.5 301,964 3.5 4.6 4.4 2.2 1.8 1.3 0.9 0.5 0.2
13 11 13 24 39 80 141 201 826 971 1,285 1,465
13 11 13 24 39 48 53 100 717 737 908 1,069
0.0 0.0 0.0 0.0 0.0 5.9 6.9 14 427 435 492 486
5.0 8.4 13 17 20 28 22 59 101 95 96 91
0.0 0.0 0.0 0.0 0.0 0.0 – 98 483 534 365 385
46 120 177 187 280 597 839 884 263 -146 -106 -163
40 111 -139 -263 -393 -611 -1,030 -1,236 -1,860 -2,277 -2,560 -2,699
17 24 27 34 41 47 51 55 56 56 58 61

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?